CRISPR THERAPEUTICS AG (CRSP)

SEC filing

CRISPR THERAPEUTICS AG

CRSP · CIK 1674416

4 · Oct 20, 2026 · Director, Chief Executive Officer Kulkarni Samarth sold 47.84K Common Shares at $49.78/unit ($2.4M); exercised options for 200K shares

Director, Chief Executive Officer Kulkarni Samarth sold 47.84K Common Shares at $49.78/unit ($2.4M); exercised options for 200K shares

Filed: Oct 20, 2026
Period: Oct 16, 2026
Accession: 0001193125-26-426878
Filer: CRISPR Therapeutics AG

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov